The LRRIQ3 Polyclonal Antibody (PACO45990) is a valuable tool for researchers studying LRRIQ3, a recently discovered protein involved in immune regulation and cell signaling pathways. This antibody, produced in rabbits, specifically detects LRRIQ3 in human samples and is validated for use in Western blot applications. By binding to LRRIQ3, this antibody allows for precise detection and analysis in various cell types, making it ideal for studies in immunology and cancer research.LRRIQ3, a relatively new player in the field of immunology, is believed to play a crucial role in immune response regulation and may have implications for a variety of diseases, including cancer and autoimmune disorders.
By targeting LRRIQ3, researchers may gain insight into novel therapeutic strategies for treating these conditions and potentially modulating immune responses in a clinical setting.In conclusion, the LRRIQ3 Polyclonal Antibody (PACO45990) offers researchers a valuable tool for investigating the role of LRRIQ3 in immune regulation and disease pathology. Its specificity and sensitivity make it a reliable option for studies looking to unravel the complexities of immune function and the potential therapeutic avenues that may arise from understanding LRRIQ3 biology.
